Retracted] The Fanconi anemia pathway sensitizes to DNA alkylating agents by inducing JNK‑p53‑dependent mitochondrial apoptosis in breast cancer cells.

Abstract

Following the publication of the above paper, a concerned reader drew to the Editor's attention that one of the fluorescence microscopic images featured in Fig.4A had previously appeared in a different form (a portion of data in a different orientation) in another article published by the same authors [Yu J, Zhao L, Li Y, Li N, He M, Bai H, Yu Z, ZhengZ, MiX, WangE and We M: Silencing of Fanconi anemia complementation groupF exhibits potent chemosensitization of mitomycinC activity in breast cancer cells. J Breast Cancer 16: 291‑299, 2013]. Furthermore, the data panel shown for the 'MDA‑MB‑231/untreated' experiment in Fig.4A in the above paper appeared to be duplicated as the 'MDA‑MB‑231/MMC+control shRNA' experiment, albeit stained differently. After having received a request from the authors to publish a corrigendum in view of the errors identified in Fig.4 of the above paper, the Editor of International Journal of Oncology has conducted an independent investigation of the matter and determined that this article should be retracted from the Journal on account of a lack of confidence in the presented data. Upon receiving this decision, the authors were not in agreement that the paper should be retracted. The Editor regrets any inconvenience that has been caused to the readership of the Journal. [the original article was published in International Journal of Oncology 45: 129‑138, 2014; DOI:10.3892/ijo.2014.2400].